Home

Pharma China Web Edition

Pharma China Archives

Online Databases

Subscription/Order/Info

Event Calendar

China Pharma Providers

About Us

	News     The Market     Industry News     Regulatory News     General Health     Legal/IPR News     Product/R&D News     API/Bulk Drug News     People in the News     Other News     Top News Worldwide Feature articles     Featured News     Editorials     Commentaries     Expert Opinions     Interviews     Case Studies     Company Profiles     Editor´s Picks General Information Full Text Title

The Market Industry News Regulatory News General Health Legal/IPR News Product/R&D News API/Bulk Drug News People in the News Other News Top News Worldwide Featured News Editorials Commentaries Expert Opinions Interviews Case Studies Company Profiles Editor´s Picks

China's Healthcare and Drug Regulatory Regime Reshuffles Again, Aiming for More ... Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on impacts of the latest plan of the Chinese government to r... (3/30/2018) Gibson: U.S.'s Growing Dependence on China For Vital Medicines A National Security Risk (4/24/2018) PharmExec: Biosimilars in China (4/24/2018) Breaking News on New Policies of Innovative Drugs in China (4/19/2018) Chinese Money Floods U.S. Biotech as Beijing Chases New Cures (4/18/2018) China Announces New Initiatives to Level the Playing Field for Innovative and Generic Drugs (4/18/2018) U.S. Businesses Worried over Chinese Policy Initiative (4/17/2018) China Will Always Be Bad at Bioethics (4/17/2018) Why Immuno-Therapy Is Leaving Markets Abuzz Across the World (4/17/2018) Goldman Sachs: China Is Beating the U.S. in the Gene Editing Arms Race (4/17/2018) Bloomburg: China Is Nationalizing Its Tech Sector (4/12/2018) PharmExec: China's CAR-T Therapy Race (4/10/2018) China Pushes Generics over Brands with Another Round of New Pharma Policies (4/6/2018) Biopharma Caught in the Crosshairs of U.S.-China Trade Tussle (4/6/2018) China's New State Market Regulatory Administration: What to Know and What to Expect (4/4/2018) Dendreon Chairwoman Figures Provenge Growth, Infrastructure Can Pave Its Way Into CAR-T (4/4/2018) NCCD, Lilly China Enter Collaboration fo...  (4/24/2018) 30 Listed Chinese Pharma Cos Spent Over ...  (4/24/2018) Chinese PD Hospital Drug Market on Stead...  (4/24/2018) CPA Releases Topline Data of 2017 Hospit...  (4/24/2018) China Announces Import Tariff Reduction ...  (4/24/2018) CNDA Issues Announcement over Matters Re...  (4/24/2018) 1/3 of Listed Chinese Pharma Cos Investe...  (4/24/2018) EpimAb and Zhejiang Teruisi Biopharma to...  (4/24/2018) CBT and CrystalGenomics Announce Partner...  (4/24/2018) Merck Group Receives Patent for CRISPR T...  (4/24/2018) Simcere, Hitgen Enter Partnership and Li...  (4/24/2018) CDE Publicizes Batch 28 of Drug Applicat...  (4/23/2018) China-Denmark Drug Regulatory Thematic S...  (4/23/2018) (free) Tocagen Licenses Greater China Rights fo...  (4/19/2018) Sinovac Announces Preliminary Results of...  (4/19/2018) CANbridge Receives IND Approval to Commence CAN008 Phase... Global Contract Pharmaceutical Manufacturing Market to R... White House Task Force Echoes Pharma Proposals Pharma Industry Reputation Rebounds Somewhat in 2016 Fresenius Steps Up Pharma M&A with Akorn, Merck KGaA... Chinese PD Hospital Drug Market on Steady Growth of 10% CAGR 20... CPA Releases Topline Data of 2017 Hospital Drug Purchase Audit State Council Removes Import Duties on Anticancers as It Propos... Nicholas Hall Projects Chinese OTC Drug Market to Grow 6% CAGR ... Nicholas Hall's Review of China's OTC Drug Market Performance 2... NCCD, Lilly China Enter Collaboration for CVD Research 30 Listed Chinese Pharma Cos Spent Over CNY 1B on Sales &... 1/3 of Listed Chinese Pharma Cos Invested Over CNY 100M into... EpimAb and Zhejiang Teruisi Biopharma to Co-develop FIT012 B... CBT and CrystalGenomics Announce Partnership to Co-develop I... China Announces Import Tariff Reduction of Some Drugs in... CNDA Issues Announcement over Matters Related to Import ... CDE Publicizes Batch 28 of Drug Applications To Be Grant... China-Denmark Drug Regulatory Thematic Seminar held in B... CDE Releases Two Draft Clinical Guidelines for Public Co... China to Restructure and Consolidate IP Regulatory Authoriti... Amended Patent Law Draft to Be Submitted for NPC Deliberatio... Novartis Entangled in New Bribery Allegation, Days After Its... Biotech Deals Targeted for More Scrutiny in New Trump Admini... UK Investigators Ask for New Info from GSK Relating to Its C... Stada: Pollution Crackdown in China Led to Pharma Supply... India to Blacklist Eight Chinese Pharma Companies for Qu... EMA Bans Amoxicillin API from Changsheng Pharma after Id... Fast Rising Price of Chinese APIs Puts Pressure on Botto... China to Restrict Production of API Producers in 28 Citi... Merck Group Receives Patent for CRISPR Technology in Chi... Sinovac Announces Preliminary Results of Phase III Trial... BeiGene Presents Clinical Data on Pamiparib in Chinese P... JHL Files Clinical Trial Application for Avastin (Bevaci... BeiGene Initiates Global Phase 2 Trial of Anti-PD-1 Anti... China Publishes First Health Management Bluebook China to Roll Out New Measures to Boost Internet + Healt... State Council Lays Out Tasks in Healthcare and Pharmaceu... China's Relatively Small Central Government Healthcare B... NCC Publishes the Latest National Cancer Statistics Recent Executive Moves Recent Executive Moves Recent Official and Executive Moves Recent Executive Moves 70 Chinese Pharma/Medical Device Entreprenuers on the Huru... China to Set Up Hainan Free Trade Zone, Further Benefiti... Upcoming Event: Pharma/Biotech Market Access & Prici... Upcoming Event: International Conference on Alzheimers, ... Upcoming Event: World Congress on Advancements in Proteo... Upcoming Event: International Conferences on Medical &am... Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector... WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...   WiCON Officially Publishes Chi...   WiCON Officially Publishes Chi...   WiCON and PharmaGuys Launch Ph...   WiCON Officially Publishes Chi...   WiCON Officially Publishes Its...

© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links